Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

The patch speeds up deep wound healing.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

The patch delivers more drugs through the skin effectively.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The new ECM patch greatly improves wound healing and tissue regeneration.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Testosterone increases certain kidney protein levels, potentially raising blood pressure.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.